Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Jose M Miro"'
Autor:
Anne Marie W Efsen, Anna Schultze, Frank A Post, Alexander Panteleev, Hansjakob Furrer, Robert F Miller, Marcelo H Losso, Javier Toibaro, Aliaksandr Skrahin, Jose M Miro, Joan A Caylà, Enrico Girardi, Mathias Bruyand, Niels Obel, Daria N Podlekareva, Jens D Lundgren, Amanda Mocroft, Ole Kirk, TB:HIV study group in EuroCoord
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145380 (2015)
Rates of TB/HIV coinfection and multi-drug resistant (MDR)-TB are increasing in Eastern Europe (EE). We aimed to study clinical characteristics, factors associated with MDR-TB and predicted activity of empiric anti-TB treatment at time of TB diagnosi
Externí odkaz:
https://doaj.org/article/4523341234a94fb19aa222054d200d42
Autor:
Ai Kawana-Tachikawa, Josep M Llibre, Isabel Bravo, Roser Escrig, Beatriz Mothe, Jordi Puig, Maria C Puertas, Javier Martinez-Picado, Julia Blanco, Christian Manzardo, Jose M Miro, Aikichi Iwamoto, Anton L Pozniak, Jose M Gatell, Bonaventura Clotet, Christian Brander, MARAVIBOOST Investigators
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e87334 (2014)
The effect of maraviroc on the maintenance and the function of HIV-1-specific T cell responses remains unknown.Subjects recently infected with HIV-1 were randomized to receive anti-retroviral treatment with or without maraviroc intensification for 48
Externí odkaz:
https://doaj.org/article/6b50d46c8fd54efbb2340efb5487afc0
Autor:
Jasmini Alagaratnam, Wolfgang Stöhr, Elizabeth Hamlyn, Kholoud Porter, Jamie Toombs, Amanda Heslegrave, Henrik Zetterberg, Magnus Gisslén, Jonathan Underwood, Mauro Schechter, Pontiano Kaleebu, Giuseppe Tambussi, Sabine Kinloch, Jose M. Miro, Anthony D. Kelleher, Abdel Babiker, John Frater, Alan Winston, Sarah Fidler
Publikováno v:
Journal of Virus Eradication, Vol 10, Iss 2, Pp 100381- (2024)
Objective: Antiretroviral therapy (ART)-conferred suppression of HIV replication limits neuronal injury and inflammation. ART interruption tests efficacy in HIV cure trials and viral rebound after ART interruption may induce neuronal injury. We inves
Externí odkaz:
https://doaj.org/article/487cf33da3b34fe190f0b5145c56c047
Autor:
Jose M Miro, Christian Manzardo, Cristina Mussini, Margaret Johnson, Antonella d'Arminio Monforte, Andrea Antinori, M John Gill, Laura Sighinolfi, Caterina Uberti-Foppa, Vanni Borghi, Caroline Sabin, Late Presenters Investigators
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e26009 (2011)
OBJECTIVES: We analyzed clinical progression among persons diagnosed with HIV at the time of an AIDS-defining event, and assessed the impact on outcome of timing of combined antiretroviral treatment (cART). METHODS: Retrospective, European and Canadi
Externí odkaz:
https://doaj.org/article/f6f152e200e14e3c9c000ed06ed3ca8f
Autor:
Raquel Martín-Iguacel, Mari Carmen Vazquez-Friol, Joaquin Burgos, Andreu Bruguera, Juliana Reyes-Urueña, Sergio Moreno-Fornés, Jordi Aceitón, Yesika Díaz, Pere Domingo, Maria Saumoy, Hernando Knobel, David Dalmau, Beatriz Borjabad, Isik Somuncu Johansen, Jose M. Miro, Jordi Casabona, Josep M. Llibre
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
ObjectivesPeople with HIV (PWH) have a higher cardiovascular risk than the general population. It remains unclear, however, whether the risk of cardiovascular disease (CVD) is higher in late HIV presenters (LP; CD4 ≤ 350 cells/μL at HIV diagnosis)
Externí odkaz:
https://doaj.org/article/4838451d69b244e39575e4b5f38ae474
Autor:
Daniel Kwakye Nomah, Juliana Reyes-Urueña, Lucía Alonso, Yesika Díaz, Sergio Moreno-Fornés, Jordi Aceiton, Andreu Bruguera, Raquel Martín-Iguacel, Arkaitz Imaz, Maria del Mar Gutierrez, Ramón W. Román, Paula Suanzes, Juan Ambrosioni, Jordi Casabona, Jose M. Miro, Josep M. Llibre, the PISCIS Study Group
Publikováno v:
Vaccines, Vol 12, Iss 1, p 44 (2023)
People with HIV (PWH) may be more susceptible to SARS-CoV-2 infection and worse clinical outcomes. We investigated the disparity in SARS-CoV-2 vaccination coverage between PWH and those without HIV (PWoH) in Catalonia, Spain, assessing primary and mo
Externí odkaz:
https://doaj.org/article/e511df49e57a45f18c2f7147e03f0236
Autor:
Adrià López-Cano, Neus Ferrer-Miralles, Julieta Sánchez, Jose Vicente Carratalá, Xavier Rodriguez Rodriguez, Imma Ratera, Judith Guasch, Oscar Q. Pich, Paula Bierge, Cristina Garcia-de-la-Maria, Jose M. Miro, Elena Garcia-Fruitós, Anna Arís
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1068 (2023)
Antibiotic resistance has exponentially increased during the last years. It is necessary to develop new antimicrobial drugs to prevent and treat infectious diseases caused by multidrug- or extensively-drug resistant (MDR/XDR)-bacteria. Host Defense P
Externí odkaz:
https://doaj.org/article/70dc93b158004430880f777cb4cd81e7
Autor:
Daniel K. Nomah, Yesika Díaz, Rosa M. Vivanco-Hidalgo, Jordi Casabona, Jose M. Miro, Juliana Reyes-Urueña
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 41:294-297
Autor:
Vance G Fowler, David T Durack, Christine Selton-Suty, Eugene Athan, Arnold S Bayer, Anna Lisa Chamis, Anders Dahl, Louis DiBernardo, Emanuele Durante-Mangoni, Xavier Duval, Claudio Fortes, Emil Fosbøl, Margaret M Hannan, Barbara Hasse, Bruno Hoen, Adolf W Karchmer, Carlos A Mestres, Cathy A Petti, María Nazarena Pizzi, Stephen D Preston, Albert Roque, Francois Vandenesch, Jan T M van der Meer, Thomas W van der Vaart, Jose M Miro
Publikováno v:
Clinical Infectious Diseases.
The microbiology, epidemiology, diagnostics, and treatment of infective endocarditis (IE) have changed significantly since the Duke Criteria were published in 1994 and modified in 2000. The International Society for Cardiovascular Infectious Diseases
Autor:
Nagendra N. Mishra, Wessam Abdelhady, Ahmed M. Elsayed, Christian Lapitan, Richard A. Proctor, Michael J. Rybak, Jose M. Miro, Arnold S. Bayer
Publikováno v:
Antimicrobial Agents and Chemotherapy. 67
The Streptococcus mitis -oralis subgroup of the viridans group streptococci (VGS) are the most common cause of infective endocarditis (IE) in many parts of the world. These organisms are frequently resistant in vitro to standard β-lactams (e.g., pen